# SentiMag® Intraoperative Comparison in Breast Cancer

> **NCT02336737** · NA · COMPLETED · sponsor: **Endomagnetics Inc** · enrollment: 160 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** SiennaXP
- **DRUG:** Technetium Tc99m Sulfur Colloid
- **DRUG:** Isosulfan blue dye

## Key facts

- **NCT ID:** NCT02336737
- **Lead sponsor:** Endomagnetics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2020-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02336737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02336737, "SentiMag® Intraoperative Comparison in Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02336737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*